JP Morgan Chase’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-896,786
| Closed | -$45.8M | – | 7867 |
|
|
2024
Q4 | $45.8M | Sell |
896,786
-226,816
| -20% | -$11.1M | ﹤0.01% | 1384 |
|
|
2024
Q3 | $46.3M | Sell |
1,123,602
-47,878
| -4% | -$2.3M | ﹤0.01% | 1378 |
|
|
2024
Q2 | $56.4M | Buy |
1,171,480
+30,767
| +3% | +$1.36M | ﹤0.01% | 1185 |
|
|
2024
Q1 | $54.7M | Sell |
1,140,713
-504,422
| -31% | -$26.9M | ﹤0.01% | 1235 |
|
|
2023
Q4 | $107M | Buy |
1,645,135
+290,759
| +21% | +$17.5M | 0.01% | 848 |
|
|
2023
Q3 | $88.6M | Buy |
1,354,376
+279,435
| +26% | +$17.6M | 0.01% | 859 |
|
|
2023
Q2 | $62.5M | Buy |
1,074,941
+725,796
| +208% | +$45.8M | 0.01% | 1022 |
|
|
2023
Q1 | $21.6M | Buy |
349,145
+33,597
| +11% | +$2.02M | ﹤0.01% | 1609 |
|
|
2022
Q4 | $20.1M | Buy |
315,548
+197,577
| +167% | +$14.3M | ﹤0.01% | 1678 |
|
|
2022
Q3 | $8.57M | Buy |
117,971
+19,338
| +20% | +$1.44M | ﹤0.01% | 2284 |
|
|
2022
Q2 | $6.71M | Sell |
98,633
-256,965
| -72% | -$18.5M | ﹤0.01% | 2514 |
|
|
2022
Q1 | $32.2M | Sell |
355,598
-27,939
| -7% | -$2.29M | ﹤0.01% | 1419 |
|
|
2021
Q4 | $35M | Sell |
383,537
-5,703
| -1% | -$489K | ﹤0.01% | 1405 |
|
|
2021
Q3 | $31.6M | Buy |
389,240
+354,264
| +1,013% | +$29.8M | ﹤0.01% | 1441 |
|
|
2021
Q2 | $3.26M | Sell |
34,976
-227,762
| -87% | -$22.1M | ﹤0.01% | 3402 |
|
|
2021
Q1 | $28.1M | Buy |
262,738
+234,597
| +834% | +$24.3M | ﹤0.01% | 1477 |
|
|
2020
Q4 | $2.46M | Buy |
28,141
+25,275
| +882% | +$1.79M | ﹤0.01% | 3338 |
|
|
2020
Q3 | $198K | Buy |
+2,866
| New | +$184K | ﹤0.01% | 4368 |
|
Other funds holding NARI
SA
IA
TCWM
PS